BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 8066707)

  • 1. Serum immunosuppressive acidic protein as an immune parameter following renal transplantation.
    Koyama I; Taguchi Y; Watanabe T; Nagashima N; Kadokura M; Omoto R
    Transplant Proc; 1994 Aug; 26(4):2157-8. PubMed ID: 8066707
    [No Abstract]   [Full Text] [Related]  

  • 2. Prospective analysis of 10 different parameters of acute renal allograft rejection.
    Müller T; Schindler S; Sprenger H; Steinmetz A; Hocke G; Ebel H; Gemsa D; Lange H
    Transplant Proc; 1992 Dec; 24(6):2731-4. PubMed ID: 1465920
    [No Abstract]   [Full Text] [Related]  

  • 3. Cytokine monitoring of infection and rejection in renal transplant recipients.
    Daniel V; Pasker S; Wiesel M; Carl S; Pomer S; Staehler G; Schnobel R; Weimer R; Opelz G
    Transplant Proc; 1995 Feb; 27(1):884-6. PubMed ID: 7879219
    [No Abstract]   [Full Text] [Related]  

  • 4. Serum C-reactive protein: a useful, economical marker of immune activation in cadaveric renal transplantation.
    Harris KR; Digard NJ; Slapak M; Lee HA
    Transplant Proc; 1995 Feb; 27(1):1046-7. PubMed ID: 7878797
    [No Abstract]   [Full Text] [Related]  

  • 5. Biomarkers for monitoring therapeutic side effects or various supratherapeutic confounders after kidney transplantation.
    Gong W; Whitcher GH; Townamchai N; Xiao X; Ge F
    Transplant Proc; 2012 Jun; 44(5):1265-9. PubMed ID: 22663998
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating ICAM-1: novel parameter of renal graft rejection.
    Stockenhuber F; Kramer G; Schenn G; Pec M; Keil M; Gnant M; Steininger R; Balcke P; Mühlbacher F
    Transplant Proc; 1993 Feb; 25(1 Pt 2):919-20. PubMed ID: 8095114
    [No Abstract]   [Full Text] [Related]  

  • 7. Evaluation of serum immunological parameters in acute renal allograft rejection.
    Yang J; Li XW; Zheng FL; Bi ZQ
    Transplant Proc; 1996 Jun; 28(3):1443-4. PubMed ID: 8658732
    [No Abstract]   [Full Text] [Related]  

  • 8. Correlation of CD3+ lymphocyte depletion with rejection and infection in renal transplants.
    McCarthy C; Light JA; Aquino A; Sasaki T; Currier C; Romolo J; Rees J; Lifton M; Kelly J
    Transplant Proc; 1993 Aug; 25(4):2477-8. PubMed ID: 8356638
    [No Abstract]   [Full Text] [Related]  

  • 9. Soluble CD23 and interleukin-2 receptor levels in renal allograft recipients.
    Beksaç M; Dalva K; Gönenç F; Dalva I; Gariboğlu S; Batur N; Cetin S
    Transplant Proc; 1993 Apr; 25(2):2145-7. PubMed ID: 8470296
    [No Abstract]   [Full Text] [Related]  

  • 10. Quantification of donor-derived DNA in serum: a new approach of acute rejection diagnosis in a rat kidney transplantation model.
    Martins PN; Mashreghi MF; Reutzel-Selke A; Neuhaus P; Volk HD; Tullius SG; Kotsch K
    Transplant Proc; 2005; 37(1):87-8. PubMed ID: 15808556
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complement activation in renal allograft recipients.
    Kirschfink M; Wienert T; Rother K; Pomer S
    Transplant Proc; 1992 Dec; 24(6):2556-7. PubMed ID: 1465864
    [No Abstract]   [Full Text] [Related]  

  • 12. Quantitative expression of T cell surface antigens in renal transplantation.
    Nanni-Costa A; Vangelista A; Stefoni S; Borgnino LC; Iannelli S; Bonomini V
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1600-2. PubMed ID: 3274390
    [No Abstract]   [Full Text] [Related]  

  • 13. Patient noncompliance as a cause of late kidney graft failure.
    Bittar AE; Keitel E; Garcia CD; Bruno RM; Silveira AE; Messias A; Garcia VD
    Transplant Proc; 1992 Dec; 24(6):2720-1. PubMed ID: 1465914
    [No Abstract]   [Full Text] [Related]  

  • 14. Evaluation of monocyte procoagulant activity as a parameter for immunologic monitoring in renal transplantation.
    Zappala SM; Khauli RB; Miller-Graziano C; Takayama TK; Stoff JS; Menon M
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1844-5. PubMed ID: 2652600
    [No Abstract]   [Full Text] [Related]  

  • 15. CD69 expression on peripheral CD8 T cells correlates with acute rejection in renal transplant recipients.
    Posselt AM; Vincenti F; Bedolli M; Lantz M; Roberts JP; Hirose R
    Transplantation; 2003 Jul; 76(1):190-5. PubMed ID: 12865808
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inducible IL-2 on CD8 lymphocytes as a postoperative predictor of rejection in renal allograft recipients.
    Langley J; Dickerman R; Vergne-Marini P; Williams J; Jensik S; Kenyon N; Anderson J
    Transplant Proc; 1993 Feb; 25(1 Pt 2):939-43. PubMed ID: 8442275
    [No Abstract]   [Full Text] [Related]  

  • 17. Reversibility from delayed hyperacute rejection in ABO-incompatible renal transplantation: histopathological findings of renal allograft biopsy.
    Sugiyama K; Arai K; Aikawa A; Miyagi M; Ohara T; Hasegawa A; Muramatsu M; Hirayama N; Tajima E; Kawamura T; Ogihara H; Hadano T; Nakano H
    Transplant Proc; 2005 Mar; 37(2):701-4. PubMed ID: 15848507
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictive value of IgG subclass levels for infectious complications in renal transplant recipients.
    Wieneke H; Otte B; Lang D; Heidenreich S
    Clin Nephrol; 1996 Jan; 45(1):22-8. PubMed ID: 8616953
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune monitoring: does the reality fulfill the promise?
    Tice DG; Heintz S; Scruggs B; Hubbell C; Szmalc FS
    Transplant Proc; 1993 Aug; 25(4):2654. PubMed ID: 8356709
    [No Abstract]   [Full Text] [Related]  

  • 20. The soluble interleukin-2 receptor as a new biological marker in diseases.
    Pizzolo G
    Allergol Immunopathol (Madr); 1991; 19(4):176-80. PubMed ID: 1818519
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.